The Activa™ RC neurostimulator is the first rechargeable deep brain stimulation device and has a 15 year longevity.* It is the thinnest device available from Medtronic today. This dual channel device is capable of delivering bilateral stimulation. Activa RC is typically implanted subcutaneously near the clavicle, and connected to an extension and leads, which are implanted in the brain.
The Activa Portfolio provides the ability to control the stimulation field with innovative interleaved pulses and patient-specific therapy groups.
Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic DBS Therapy for Parkinson's Disease is indicated for adjunctive therapy in reducing some of the symptoms in individuals with levodopa-responsive Parkinson's disease of at least 4 years' duration that are not adequately controlled with medication, including motor complications of recent onset (from 4 months to 3 years) or motor complications of longer-standing duration.
Unilateral thalamic stimulation of the ventral intermediate nucleus of the thalamus (VIM) using Medtronic DBS Therapy for Tremor is indicated for the suppression of tremor in the upper extremity. The system is intended for use in patients who are diagnosed with Essential Tremor or Parkinsonian tremor not adequately controlled by medications and where the tremor constitutes a significant functional disability. The safety or effectiveness of this therapy has not been established for bilateral stimulation.
In 2009, when we launched the first rechargeable technology in the DBS market, we felt confident that our devices would provide predictable performance for up to nine years. This confidence was based largely on accelerated lab-testing. Today, as part of our commitment to the Medtronic mission to DBS therapy, we have invested in post-market analysis and continuous device testing to validate our predictive models, and confidently extend device service life from 9 to 15 years.*
Medtronic gives you the first safe† access to MRI anywhere on the body for diagnosing health conditions in DBS patients. Eligible patients with an Activa RC neurostimulator may have an MRI scan anywhere on the body under certain conditions. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems and DBS MRI Eligibility Sheet for a complete list of conditions and instructions for use (available on the Medtronic Manuals Library).
Patient-specific data — including historical settings and therapeutic response — is stored in the neurostimulator for easy access from the clinician programmer.
Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Activa RC) or model number (37612). You may also call 800-961-9055 for a copy of a manual.
|Weight||40 g (1.4 oz)|
|Height||54 mm (2.1 in)|
|Length||54 mm (2.1 in)|
Activa™ RC devices eligible for the service life extension and the supplemental limited warranty are those devices sold in the US that have been successfully interrogated with the Medtronic Activa Clinician Programmer (tablet) prior to reaching End of Service (EOS).
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions.